CDKN1C and fetal growth restriction: In adults with IUGR, Cyclin-dependent kinase inhibitor 1C (CDKN1C), a cell proliferation regulator that affects pancreatic β cells, can have a mutation at chromosome 11p15, resulting in decreased fetal growth, growth deficiency, and the onset of diabetes at a young age (80).